Avalo Therapeutics
AVTX
AVTX
20 hedge funds and large institutions have $68.3M invested in Avalo Therapeutics in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
6
Reduced
7
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$151K
Top Buyers
1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$6.21M |
2 |
AC
Armistice Capital
New York
|
+$2.03M |
3 |
PM
Prosight Management
Dallas,
Texas
|
+$994K |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$668K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$102K |
Top Sellers
1 |
Millennium Management
New York
|
-$150K |
2 |
DBIA
Dumont & Blake Investment Advisors
Princeton,
New Jersey
|
-$93K |
3 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
-$81.7K |
4 |
Goldman Sachs
New York
|
-$81K |
5 |
Invesco
Atlanta,
Georgia
|
-$56.2K |